XR-5942

N/A

Report date: 2023/05/22 10:18:18

Base Information

Drug NameXR-5942
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionDNA topoisomerase inhibitors
TargetsDNA topoisomerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXenova Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXenova Group Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A